Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | |
Div Cover | n/a | |
Op Mrgn | 16.8% | |
ROCE | 16.9% |
Latest | F'cast | |
---|---|---|
P/E | 26.4 | |
PEG | 0.4 | |
Pr/Revenue | 4.3 | |
Pr/Book | 3.0 |
Latest | F'cast | |
---|---|---|
Revenue | 8.9% | |
PBT | 57.7% | |
EPS | 74.5% | |
DPS | n/a |
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-19 | 2,158.76 | 486.79 | 208.00¢ | 42.0 | 0.1 | +300% | n/a | 0.0% |
31-Dec-20 | 2,666.70 | (232.22) | (136.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-21 | 2,986.27 | 570.44 | 430.00¢ | 17.1 | n/a | n/a | n/a | 0.0% |
31-Dec-22 | 3,394.64 | 529.12 | 153.00¢ | 52.5 | n/a | -64% | n/a | 0.0% |
31-Dec-23 | 3,695.65 | 834.22 | 267.00¢ | 23.5 | 0.3 | +74% | n/a | 0.0% |
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-24 | 4,204.01 | 369.53 | 130.58¢ | 53.9 | n/a | -51% | n/a | 0.0% |
31-Dec-25 | 4,638.83 | 1,417.05 | 614.03¢ | 11.5 | 0.0 | +370% | n/a | 0.0% |
31-Dec-26 | 5,137.81 | 1,792.07 | 774.28¢ | 9.1 | 0.3 | +26% | n/a | 0.0% |
Copyright © 2024 FactSet Research Systems Inc. All rights reserved.
FDA grants EUA for Eli Lilly treatment in conjun... | 20-Nov-2020 | ShareCast |
Currency | US Dollars |
Share Price | $ 70.39 |
Change Today | $ -0.66 |
% Change | -0.93 % |
52 Week High | $83.38 |
52 Week Low | $51.18 |
Volume | 2,145,323 |
Shares Issued | 224.29m |
Market Cap | $15,788m |
RiskGrade | 196 |
Strong Buy | 7 |
Buy | 3 |
Neutral | 11 |
Sell | 1 |
Strong Sell | 0 |
Total | 22 |
Time | Volume / Share Price |
15:59 | 100 @ $70.39 |
15:59 | 200 @ $70.35 |
15:59 | 246 @ $70.35 |
15:59 | 100 @ $70.35 |
15:59 | 303 @ $70.36 |
You are here: research